ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75
  • Home
  • Archive
  • Contact
✕
  • Filter by
  • Categories
  • Tags
  • Authors
  • Show all
  • All
  • Active Clinical Trials
  • From the Co-Chairs
  • Institution Spotlights
  • News in Brief
  • People
  • Special Topics
  • Trial Results
  • All
  • AACR
  • Acute lymphoblastic leukemia (ALL)
  • Acute myeloid leukemia
  • Acute myeloid leukemia (AML)
  • Acute promyelocytic leukemia
  • Adolescents and young adults
  • Advanced melanoma
  • Advanced practice providers
  • Advocacy
  • Anal cancer
  • ARPA-H
  • ASCO
  • Awards
  • AYA cancer
  • B-cell lymphoma
  • Big data
  • Biostatistics
  • Bladder cancer
  • Blood cancer
  • Blood cancers
  • Brain cancer
  • Breast cancer
  • Cancer
  • Cancer care delivery research
  • Cancer control
  • Cancer research
  • Cancer research policy
  • Cancer screening
  • Cancer surveillance
  • Cardiotoxicity
  • CBPF
  • Chemoimmunotherapy
  • Chemotherapy
  • Chronic lymphocytic leukemia
  • Chronic myelogenous leukemia
  • Chronic myeloid leukemia
  • Clinical trial
  • Clinical trials
  • Colorectal cancer
  • Colorectal liver metastases
  • ComboMATCH
  • Comis Symposium
  • Communication
  • Community oncology
  • Cooperative Group cancer research
  • Correlative science
  • COVID-19
  • CT scans
  • Data science
  • DCIS
  • De-escalation
  • Deep learning
  • DEI
  • Developmental therapeutics
  • Diversity
  • EGFR
  • Engineering
  • Esophagus cancer
  • Ethics
  • Federally-funded cancer research
  • Financial hardship
  • Gallbladder cancer
  • Gastric cancer
  • Gastroesophageal junction cancer
  • GBM
  • Gender equity
  • Genetic testing
  • Genomics
  • Geriatric oncology
  • GI cancer
  • Glioblastoma
  • GM-CSF
  • Green tea catechins
  • Group Meeting
  • GU cancer
  • Head and neck cancer
  • Head and neck squamous cell carcinoma
  • health care
  • Health care administration
  • Health equity
  • Hematology
  • Hepatic arterial infusion
  • HER2-positive breast cancer
  • Hormone therapy
  • Imaging
  • Immune checkpoint inhibitors
  • Immunotherapy
  • In memory
  • Institution Evaluation
  • Just-in-time clinical trials
  • Kidney cancer
  • Language
  • Leadership
  • Leukemia
  • Liver cancer
  • Lung cancer
  • Lung inflammation
  • Lymphoblastic lymphoma
  • Lymphoma
  • Mammography
  • Meetings
  • Melanoma
  • Mentorship
  • Mesothelioma
  • Misinformation
  • Multiple myeloma
  • Myelodysplastic neoplasms
  • Myelodysplastic syndromes
  • Myeloid malignancies
  • Myeloma
  • myeloMATCH
  • National Cancer Act
  • Natural language processing
  • NCI
  • NCI-Designated Comprehensive Cancer Centers
  • NCI-MATCH
  • NCORP
  • NCTN Grant
  • Neuroendocrine tumors
  • Non-Hodgkin lymphoma
  • Non-small cell lung cancer
  • NSCLC
  • Older adults
  • Ovarian cancer
  • Pancreatic cancer
  • Pancreatic cyst
  • Pancreatic cysts
  • Pancreatic NETs
  • Pathology
  • Patient registry
  • Patient-reported outcomes
  • Penile cancer
  • Peripheral neuropathy
  • Personalized medicine
  • Personalized screening
  • Pneumonitis
  • Policy
  • Pragmatic clinical trials
  • Precision medicine
  • Prevention
  • Prostate cancer
  • Proteasome inhibitors
  • Public-private partnerships
  • Racism
  • Radiation
  • Radiology
  • Rare disease
  • Real-world data
  • Recurrence
  • Renal cell
  • Renal cell carcinoma
  • Reproductive health
  • Research results
  • Retroperitoneal sarcoma
  • Sarcoma
  • Scholarship
  • Sexuality
  • Side effects
  • Smoking cessation
  • Smoldering multiple myeloma
  • Social determinants of health
  • Social genomics
  • Stomach cancer
  • Survivorship
  • Symptom control
  • Symptom management
  • Symptom science
  • Targeted therapy
  • Throat cancer
  • Thyroid cancer
  • TMIST
  • Tobacco cessation
  • Translational research
  • Urinary tract cancer
  • Vaccination
  • Women in oncology
  • Young investigators
  • All
  • Diane Dragaud
  • ECOG-ACRIN Staff
  • ECOG-ACRIN Staff
November 1, 2019
November 1, 2019
Categories
  • Active Clinical Trials

Now Enrolling: EA4181 Trial For Mantle Cell Lymphoma

This new trial seeks to define the optimal upfront treatment for an aggressive form of lymphoma
Do you like it?
0 Read more
November 1, 2019
November 1, 2019
Categories
  • Special Topics

Improving Cancer Care For Sexual and Gender Minorities

Dr. Edith Mitchell describes a current focus of the Health Equity Committee
Do you like it?
0 Read more
November 1, 2019
Joseph Sparano, MD headshot
November 1, 2019
Categories
  • People
  • Special Topics

San Antonio Breast Cancer Symposium Honors EA Vice Chair Joseph A. Sparano

A career distinguished by leadership, collaboration, and practice-changing achievements in clinical and translational breast cancer research that have improved the lives of patients
Do you like it?
0 Read more
November 1, 2019
November 1, 2019
Categories
  • People
  • Special Topics

EA Features Eight Young Investigators

The Young Investigator Symposium is a professional mentoring event that takes place annually at the fall Group Meeting
Do you like it?
0 Read more
Prev page
1234567891011121314

A blog to share information with our members, staff, and the cancer research community

✕

Categories

  • From the Co-Chairs
  • Active Clinical Trials
  • Institution Spotlights
  • Special Topics
  • People
  • News in Brief
  • Trial Results
  • Active ECOG-ACRIN Trials
  • ECOG-ACRIN.org

Tags

Acute lymphoblastic leukemia (ALL) Advanced practice providers Advocacy ASCO Bladder cancer Breast cancer Cancer care delivery research Cancer control Cancer screening Cancer surveillance Chemotherapy Clinical trials Colorectal cancer Comis Symposium COVID-19 Diversity GI cancer Group Meeting Head and neck cancer Head and neck squamous cell carcinoma Health equity Immunotherapy In memory Kidney cancer Leadership Leukemia Lung cancer Lymphoma Melanoma Mentorship Myeloma NCI NCI-MATCH NCORP Non-small cell lung cancer Pancreatic cancer Precision medicine Prostate cancer Real-world data Research results Sarcoma Social determinants of health Survivorship Targeted therapy TMIST
STAY UP TO DATE

Opt in to ensure we deliver this monthly blog directly to your inbox. We will never share your email.

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2025 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc